IL123619A0 - 2-[2- [(2-Hydroxyehtyl) amino] ethyl]-5- [[2-Methylamino) ethyl] amino] indazolo [4,3-gh] isoquinolin-6 (2H)-one as antitumor agent - Google Patents
2-[2- [(2-Hydroxyehtyl) amino] ethyl]-5- [[2-Methylamino) ethyl] amino] indazolo [4,3-gh] isoquinolin-6 (2H)-one as antitumor agentInfo
- Publication number
- IL123619A0 IL123619A0 IL12361996A IL12361996A IL123619A0 IL 123619 A0 IL123619 A0 IL 123619A0 IL 12361996 A IL12361996 A IL 12361996A IL 12361996 A IL12361996 A IL 12361996A IL 123619 A0 IL123619 A0 IL 123619A0
- Authority
- IL
- Israel
- Prior art keywords
- ethyl
- amino
- indazolo
- hydroxyehtyl
- isoquinolin
- Prior art date
Links
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 2
- KPJTZBXDTYGLSA-UHFFFAOYSA-N C1=CC(C(=O)C=2C3=CN=CC=2)=C2C3=NNC2=C1 Chemical compound C1=CC(C(=O)C=2C3=CN=CC=2)=C2C3=NNC2=C1 KPJTZBXDTYGLSA-UHFFFAOYSA-N 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001904A IT1277576B1 (it) | 1995-09-13 | 1995-09-13 | 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale |
| PCT/EP1996/003935 WO1997010245A1 (en) | 1995-09-13 | 1996-09-09 | 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL123619A0 true IL123619A0 (en) | 1998-10-30 |
Family
ID=11372237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12361996A IL123619A0 (en) | 1995-09-13 | 1996-09-09 | 2-[2- [(2-Hydroxyehtyl) amino] ethyl]-5- [[2-Methylamino) ethyl] amino] indazolo [4,3-gh] isoquinolin-6 (2H)-one as antitumor agent |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6034092A (cs) |
| EP (1) | EP0876369A1 (cs) |
| JP (1) | JPH11512409A (cs) |
| KR (1) | KR19990044614A (cs) |
| CN (1) | CN1196055A (cs) |
| AR (1) | AR003997A1 (cs) |
| AU (1) | AU6988296A (cs) |
| BR (1) | BR9610601A (cs) |
| CZ (1) | CZ286654B6 (cs) |
| HU (1) | HUP9901348A3 (cs) |
| IL (1) | IL123619A0 (cs) |
| IT (1) | IT1277576B1 (cs) |
| NO (1) | NO981093D0 (cs) |
| WO (1) | WO1997010245A1 (cs) |
| ZA (1) | ZA967706B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6747039B2 (en) * | 2002-03-12 | 2004-06-08 | Albany Molecular Research, Inc. | Aza-benzothiopyranoindazoles with antitumor activity |
| US20060189546A1 (en) * | 2005-01-28 | 2006-08-24 | Ajami Alfred M | Compounds for treating autoimmune and demyelinating diseases |
| CN103787970A (zh) * | 2014-01-14 | 2014-05-14 | 北京万全德众医药生物技术有限公司 | 一锅煮法制备6，9-二氟苯并异喹啉-5，10-二酮的工艺 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE56782B1 (en) * | 1982-07-23 | 1991-12-18 | Warner Lambert Co | Substituted anthra(1,9-cd)pyrazol-6(2h)-ones |
| PT662076E (pt) * | 1992-09-08 | 2001-09-28 | Univ Vermont | Isoquinoindazol-6-(2h)-onas substituidas por 2-aminoalquil-5-aminoalquilamino com actividade antitumor |
| US5519029A (en) * | 1992-09-08 | 1996-05-21 | Boehringer Mannheim Italia, S.P.A. | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones |
| US5596097A (en) * | 1994-03-08 | 1997-01-21 | The University Of Vermont | Hetero-annulated indazoles |
-
1995
- 1995-09-13 IT IT95MI001904A patent/IT1277576B1/it active IP Right Grant
-
1996
- 1996-09-09 CN CN96196912A patent/CN1196055A/zh active Pending
- 1996-09-09 JP JP9511638A patent/JPH11512409A/ja active Pending
- 1996-09-09 HU HU9901348A patent/HUP9901348A3/hu unknown
- 1996-09-09 BR BR9610601-8A patent/BR9610601A/pt not_active Application Discontinuation
- 1996-09-09 EP EP96931049A patent/EP0876369A1/en not_active Withdrawn
- 1996-09-09 KR KR1019980701865A patent/KR19990044614A/ko not_active Ceased
- 1996-09-09 CZ CZ1998750A patent/CZ286654B6/cs not_active IP Right Cessation
- 1996-09-09 US US09/029,742 patent/US6034092A/en not_active Expired - Lifetime
- 1996-09-09 WO PCT/EP1996/003935 patent/WO1997010245A1/en not_active Application Discontinuation
- 1996-09-09 IL IL12361996A patent/IL123619A0/xx unknown
- 1996-09-09 AU AU69882/96A patent/AU6988296A/en not_active Abandoned
- 1996-09-12 AR ARP960104329A patent/AR003997A1/es unknown
- 1996-09-12 ZA ZA967706A patent/ZA967706B/xx unknown
-
1998
- 1998-03-12 NO NO981093A patent/NO981093D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9610601A (pt) | 1999-12-21 |
| CZ75098A3 (cs) | 1998-07-15 |
| CN1196055A (zh) | 1998-10-14 |
| IT1277576B1 (it) | 1997-11-11 |
| AU6988296A (en) | 1997-04-01 |
| ITMI951904A1 (it) | 1997-03-13 |
| NO981093L (no) | 1998-03-12 |
| KR19990044614A (ko) | 1999-06-25 |
| HUP9901348A2 (hu) | 1999-08-30 |
| HUP9901348A3 (en) | 2000-03-28 |
| WO1997010245A1 (en) | 1997-03-20 |
| US6034092A (en) | 2000-03-07 |
| CZ286654B6 (cs) | 2000-05-17 |
| JPH11512409A (ja) | 1999-10-26 |
| NO981093D0 (no) | 1998-03-12 |
| AR003997A1 (es) | 1998-09-30 |
| ZA967706B (en) | 1997-03-25 |
| EP0876369A1 (en) | 1998-11-11 |
| ITMI951904A0 (it) | 1995-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
| GB2307649B (en) | Running body | |
| PL334218A1 (en) | Derivatives of 2-(purin-9-yl)-tetrahydrofurane 3,4-diole | |
| IL122212A0 (en) | Rapamycin derivatives | |
| AU3698295A (en) | Amino purine-beta -d-ribofuranuronamide derivatives | |
| HU9801587D0 (en) | 5h-thiazolo[3,2-a]pyrimidine derivatives | |
| PL338563A1 (en) | Substituted derivatives of 1,2,3,4-tetrahydronaphtalene | |
| HUP0004234A3 (en) | Dolastatin 15 derivatives | |
| PL324992A1 (en) | Novel derivatives of 2,3-dioxotetrahydoquinoxaline | |
| PL339137A1 (en) | 6,9-bridged derivatives of erythromycin | |
| ZA969221B (en) | Indolealkyl derivatives of benzodioxanmethylamine. | |
| PL340253A1 (en) | 6,11-bridged derivatives of erythromycin | |
| AU6798598A (en) | 5'-Deoxy-cytidine derivatives | |
| PL330277A1 (en) | Derivatives of 2,4-diaminopyrimidine | |
| CY2227B1 (en) | Benzothiazolone derivatives | |
| AP9500731A0 (en) | 1,5 benzodiazepine derivatives | |
| PL342060A1 (en) | Derivatives of 1,3,4-oxadiaxolone | |
| ZA968770B (en) | Cyclopeptide derivatives | |
| IL123619A0 (en) | 2-[2- [(2-Hydroxyehtyl) amino] ethyl]-5- [[2-Methylamino) ethyl] amino] indazolo [4,3-gh] isoquinolin-6 (2H)-one as antitumor agent | |
| IL119744A0 (en) | Use of 8,9-dehydroestrone | |
| AU8009698A (en) | Body suit | |
| IL130704A0 (en) | Cyanophosphonate derivatives | |
| PL107114U1 (en) | Seat body | |
| ZA95107B (en) | 3-(7-oxo-1-aza-4-oxabicyclo [3.2.0]hept-3-yl) alanine derivatives as antitumor agent | |
| SI0991658T1 (sl) | Derivati dolastatina 15 |